Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of ustekinumab in real clinical practice. Retrospective multicentre study. ARAINF cohort.
Casas Deza D, García López S, Lafuente Blasco M, Vicente Lidón R, Nerín de la Puerta J, Peña Gonzalez E, Ber Nieto Y, Charro Calvillo M, Alcalá Escriche MJ, Gomollón García F, Arroyo Villarino M. Casas Deza D, et al. Among authors: arroyo villarino m. Gastroenterol Hepatol. 2020 Mar;43(3):126-132. doi: 10.1016/j.gastrohep.2019.09.011. Epub 2019 Dec 19. Gastroenterol Hepatol. 2020. PMID: 31866167 English, Spanish.
[Hemoperitoneum as a complication of diagnostic colonoscopy].
Salvador Milian E, Lorente Perez S, Arroyo Villarino MT, Sainz Samitier R. Salvador Milian E, et al. Among authors: arroyo villarino mt. Gastroenterol Hepatol. 1999 Aug-Sep;22(7):377. Gastroenterol Hepatol. 1999. PMID: 10535213 Spanish. No abstract available.
Unravelling the cellular response to the SARS-COV-2 vaccine in inflammatory bowel disease patients on biologic drugs.
Martínez-Domínguez SJ, García-Mateo S, Sainz-Arnal P, Martínez-García J, Gallego-Llera B, Lozano-Limones MJ, Hidalgo S, Gargallo-Puyuelo CJ, Latre-Santos M, Nocito-Colon MML, Martínez-Lostao L, Refaie E, Arroyo-Villarino MT, Del Rio-Nechaevsky M, Ramirez-Labrada A, Pardo J, Gomollón F, Baptista PM. Martínez-Domínguez SJ, et al. Among authors: arroyo villarino mt. Sci Rep. 2023 Dec 27;13(1):23061. doi: 10.1038/s41598-023-50537-y. Sci Rep. 2023. PMID: 38155275 Free PMC article.
Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease.
Martínez-Domínguez SJ, García-Mateo S, Gargallo-Puyuelo CJ, Gallego Llera B, Refaie E, Callau P, Mendi C, Baptista PM, Hernández Ainsa M, Arroyo-Villarino MT, López de la Cruz J, Martínez-García J, Alfambra E, Simón Marco MÁ, Ampuero J, Gomollón F. Martínez-Domínguez SJ, et al. Among authors: arroyo villarino mt. Eur J Intern Med. 2024 Feb;120:99-106. doi: 10.1016/j.ejim.2023.10.019. Epub 2023 Oct 21. Eur J Intern Med. 2024. PMID: 37872034
Lifestyle Can Exert a Significant Impact on the Development of Metabolic Complications and Quality Life in Patients with Inflammatory Bowel Disease.
García-Mateo S, Martínez-Domínguez SJ, Gargallo-Puyuelo CJ, Arroyo Villarino MT, Laredo De La Torre V, Gallego B, Alfambra E, Gomollón F. García-Mateo S, et al. Among authors: arroyo villarino mt. Nutrients. 2023 Sep 14;15(18):3983. doi: 10.3390/nu15183983. Nutrients. 2023. PMID: 37764769 Free PMC article.
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.
Martínez-Domínguez SJ, García-Mateo S, Gargallo-Puyuelo CJ, Gallego-Llera B, Callau P, Mendi C, Arroyo-Villarino MT, Simón-Marco MÁ, Ampuero J, Gomollón F. Martínez-Domínguez SJ, et al. Among authors: arroyo villarino mt. Inflamm Bowel Dis. 2023 Aug 22:izad175. doi: 10.1093/ibd/izad175. Online ahead of print. Inflamm Bowel Dis. 2023. PMID: 37607330
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Peyrin-Biroulet L; STARDUST study group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 Feb 1. Lancet Gastroenterol Hepatol. 2022. PMID: 35120656 Clinical Trial.
Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease.
Refaie E, García Mateo S, Martínez Domínguez SJ, Gargallo-Puyuelo CJ, Lario Quilez L, Carrera-Lasfuentes P, Arroyo Villarino MT, Gomollón García F. Refaie E, et al. Among authors: arroyo villarino mt. Gastroenterol Hepatol. 2022 Feb;45(2):114-122. doi: 10.1016/j.gastrohep.2021.03.012. Epub 2021 May 21. Gastroenterol Hepatol. 2022. PMID: 34023473 Free PMC article.
14 results